Assignee
INNATE TUMOR IMMUNITY INC
US·21 granted patents·3 pending applications·31 citations·filing 2017–2023
Top patents by PatentIndex Score
24 records- 0193US10604542B2Cyclic dinucleotides for treating conditions associated with sting activity such as cancerINNATE TUMOR IMMUNITY INC·Filed 2017·Granted Mar 31, 2020·5 cites·30 claims
- 0293US10556903B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2017·Granted Feb 11, 2020·12 cites·5 claims
- 0392US10533005B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2018·Granted Jan 14, 2020·9 cites·41 claims
- 0489US10961270B2Compounds and compositions for treating conditions associated with sting activityINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Mar 30, 2021·2 cites·7 claims
- 0587US11344543B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2018·Granted May 31, 2022·2 cites·25 claims
- 0685US12351580B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2023·Granted Jul 8, 2025·0 cites·6 claims
- 0778US11072612B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2019·Granted Jul 27, 2021·1 cites·5 claims
- 0873US12171756B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2022·Granted Dec 24, 2024·0 cites·10 claims
- 0973US11827632B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2021·Granted Nov 28, 2023·0 cites·23 claims
- 1071US11505571B2Compounds and compositions for treating conditions associated with sting activityINNATE TUMOR IMMUNITY INC·Filed 2021·Granted Nov 22, 2022·0 cites·7 claims
- 1164US2020157096A1Nlrp3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2019·Application pending·0 cites
- 1263US11827597B2Substituted 4-amino-1H-imidazo[4,5-c]quinoline compounds and improved methods for their preparationINNATE TUMOR IMMUNITY INC·Filed 2022·Granted Nov 28, 2023·0 cites·2 claims
- 1363US2019064146A1Immune cells having increased immunity or resistance to an immunosuppressive cytokine and use of the sameINNATE TUMOR IMMUNITY INC·Filed 2018·Application pending·0 cites
- 1459US11572360B2Substituted 4-amino-1H-imidazo[4,5-c]quinoline compounds and improved methods for their preparationINNATE TUMOR IMMUNITY INC·Filed 2019·Granted Feb 7, 2023·0 cites·2 claims
- 1558US10723756B2Cyclic dinucleotides for treating conditions associated with STING activity such as cancerINNATE TUMOR IMMUNITY INC·Filed 2017·Granted Jul 28, 2020·0 cites·2 claims
- 1655US12201627B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2019·Granted Jan 21, 2025·0 cites·17 claims
- 1754US12391675B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Aug 19, 2025·0 cites·13 claims
- 1852US12492200B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2021·Granted Dec 9, 2025·0 cites·12 claims
- 1951US12187706B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Jan 7, 2025·0 cites·18 claims
- 2050US12338228B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Jun 24, 2025·0 cites·12 claims
- 2150US12150937B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Nov 26, 2024·0 cites·16 claims
- 2248US12024513B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2019·Granted Jul 2, 2024·0 cites·17 claims
- 2345US12037344B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2019·Granted Jul 16, 2024·0 cites·34 claims
- 2441US2019345191A1Cyclic dinucleotide analogs for treating conditions associated with sting (stimulator of interferon genes) activityINNATE TUMOR IMMUNITY INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when INNATE TUMOR IMMUNITY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →